In addition, the release of hypoxia-induced-factors (HIF) 1 and 2 leads to overexpression of inhibitory checkpoints CTLA4, TIM3, and LAG3 through the generation of VEGF, leading to a more complex tumor microenvironment and thus resistance to ICI[72]. The gene discussed is VEGFA; the disease is neoplasm.